• Shopping Cart
    There are no items in your cart

CLSI H60 A : 1ED 2014

Superseded

Superseded

A superseded Standard is one, which is fully replaced by another Standard, which is a new edition of the same Standard.

View Superseded by

LABORATORY TESTING FOR THE LUPUS ANTICOAGULANT

Superseded date

28-11-2019

Superseded by

CLSI H60 A : 2014(R2019)

Published date

04-04-2014

Sorry this product is not available in your region.

Abstract
Committee Membership
Foreword
1 Scope
2 Introduction
3 Standard Precautions
4 Terminology
5 Equipment
6 Validation of Assay Systems
7 Preexamination Issues (Criterion A)
8 Preliminary Examination Issues
9 Principles of Lupus Anticoagulant Assays
10 Assays to Screen for the Presence of Lupus
   Anticoagulant (Criterion B)
11 Assays of Confirm the Presence of Lupus
   Anticoagulant (Criterion C)
12 Mixing Test as Applied to Screening, Confirmatory, and
   Integrated Assays (Criterion D)
13 Post examination Issues
14 Quality Control and Quality Assurance
15 Harmonization of CLSI Lupus Anticoagulant Guideline With
   Other Guidelines
References
Appendix A - Algorithmic Approach to Lupus Anticoagulant
             Testing
Appendix B - Establishing Reference Intervals and Cutoff Values
Appendix C - Lupus Anticoagulant Testing in Relationship to
             Coagulation Pathways
Appendix D - Diagrammatic Principles for Lupus Anticoagulant
             Test
Appendix E - Table of Interferences and Limitations for Specific
             Lupus Anticoagulant Tests
Appendix F - Formulas and Examples for Calculating Test Results
Appendix G1 - Interpretive Comments and Rationale for Comments
              Based on Patient Examples (Data)
Appendix G2 - Interpretive Comments and Rationale for Comments
              Based on Patient Examples (Comments)
The Quality Management System Approach
Related CLSI Reference Materials

Gives guidance and recommendations regarding the proper collection and handling of the specimen; descriptions and limitations of screening and confirmatory assays, and mixing tests used to identify lupus anticoagulant (LA); determination of cutoff values and calculations associated with the various assays; and interpretation of test results in an LA panel.

DocumentType
Miscellaneous Product
PublisherName
Clinical Laboratory Standards Institute
Status
Superseded
SupersededBy

CLSI EP5 A2 : 2ED 2004 EVALUATION OF PRECISION PERFORMANCE OF QUANTITATIVE MEASUREMENT METHODS
CLSI H21 A5 : 5ED 2008 COLLECTION, TRANSPORT, AND PROCESSING OF BLOOD SPECIMENS FOR TESTING PLASMA-BASED COAGULATION ASSAYS AND MOLECULAR HEMOSTASIS ASSAYS
CLSI H57 A : 1ED 2008 PROTOCOL FOR THE EVALUATION, VALIDATION, AND IMPLEMENTATION OF COAGULOMETERS
CLSI EP12 A2 : 2ED 2008 USER PROTOCOL FOR EVALUATION OF QUALITATIVE TEST PERFORMANCE
CLSI EP24 A2 : 2ED 2011 ASSESSMENT OF THE DIAGNOSTIC ACCURACY OF LABORATORY TESTS USING RECEIVER OPERATING CHARACTERISTIC CURVES
CLSI EP9 A3 : 3ED 2013 MEASUREMENT PROCEDURE COMPARISON AND BIAS ESTIMATION USING PATIENT SAMPLES
CLSI EP6 A : 1ED 2003 EVALUATION OF THE LINEARITY OF QUANTITATIVE MEASUREMENT PROCEDURES - A STATISTICAL APPROACH
CLSI M29 A3 : 3ED 2005 ACQUIRED INFECTIONS; APPROVED GUIDELINE
CLSI EP15 A2 : 2ED 2006 USER VERIFICATION OF PERFORMANCE FOR PRECISION AND TRUENESS
CLSI GP41 A6 : 6ED 2007 PROCEDURES FOR THE COLLECTION OF DIAGNOSTIC BLOOD SPECIMENS BY VENIPUNCTURE
CLSI H47 A2 : 2ED 2008 ONE-STAGE PROTHROMBIN TIME (PT) TEST AND ACTIVATED PARTIAL THROMBOPLASTIN TIME (APTT) TEST

Access your standards online with a subscription

Features

  • Simple online access to standards, technical information and regulations.

  • Critical updates of standards and customisable alerts and notifications.

  • Multi-user online standards collection: secure, flexible and cost effective.